{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19091578",
  "DateCompleted": {
    "Year": "2009",
    "Month": "03",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2012",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2008",
        "Month": "12",
        "Day": "03"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bmc.2008.11.061"
    ],
    "Journal": {
      "ISSN": "1464-3391",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "2",
        "PubDate": {
          "Year": "2009",
          "Month": "Jan",
          "Day": "15"
        }
      },
      "Title": "Bioorganic & medicinal chemistry",
      "ISOAbbreviation": "Bioorg Med Chem"
    },
    "ArticleTitle": "Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.",
    "Pagination": {
      "StartPage": "621",
      "EndPage": "624",
      "MedlinePgn": "621-4"
    },
    "Abstract": {
      "AbstractText": [
        "Human rhinovirus (HRV) is the most important etiologic agent causing common colds. No effective anti-HRV agents are currently available. In this paper we describe the synthesis and the evaluation of novel chloropyridazine derivatives (compounds 5a-g) as potent human rhinovirus (HRV) capsid-binding inhibitors. Results showed that compound 5e and 5f exhibited effective anti-HRV activity against HRV-2 and HRV-14. In addition, compound 5e and 5f showed lower cytotoxicity than Pirodavir."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Beijing 100850, China."
          }
        ],
        "LastName": "Fan",
        "ForeName": "Shi-Yong",
        "Initials": "SY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zheng",
        "ForeName": "Zhi-Bing",
        "Initials": "ZB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mi",
        "ForeName": "Chun-Lai",
        "Initials": "CL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zhou",
        "ForeName": "Xin-Bo",
        "Initials": "XB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yan",
        "ForeName": "Hui",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gong",
        "ForeName": "Ze-Hui",
        "Initials": "ZH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Li",
        "ForeName": "Song",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Bioorg Med Chem",
    "NlmUniqueID": "9413298",
    "ISSNLinking": "0968-0896"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Capsid Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pyridazines"
    },
    {
      "RegistryNumber": "449GLA0653",
      "NameOfSubstance": "pyridazine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "chemical synthesis",
        "pharmacology"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors"
      ],
      "DescriptorName": "Capsid Proteins"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemical synthesis",
        "pharmacology"
      ],
      "DescriptorName": "Pyridazines"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Rhinovirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Structure-Activity Relationship"
    }
  ]
}